JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M708847200 on March 3, 2008

J. Biol. Chem., Vol. 283, Issue 18, 12175-12187, May 2, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/18/12175    most recent
M708847200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Valentine, W. J.
Right arrow Articles by Tigyi, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valentine, W. J.
Right arrow Articles by Tigyi, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Subtype-specific Residues Involved in Ligand Activation of the Endothelial Differentiation Gene Family Lysophosphatidic Acid Receptors*Formula

William J. Valentine{ddagger}, James I. Fells§, Donna H. Perygin§, Sana Mujahid{ddagger}, Kazuaki Yokoyama{ddagger}, Yuko Fujiwara{ddagger}, Ryoko Tsukahara{ddagger}, James R. Van Brocklyn, Abby L. Parrill§, and Gabor Tigyi{ddagger}1

From the {ddagger}Department of Physiology, The University of Tennessee Health Science Center, Memphis, Tennessee 38163, the §Department of Chemistry and Computational Research on Materials Institute, University of Memphis, Memphis, Tennessee 38152, and the Department of Pathology, Ohio State University, Columbus, Ohio 43210

Lysophosphatidic acid (LPA) is a ligand for three endothelial differentiation gene family G protein-coupled receptors, LPA1–3. We performed computational modeling-guided mutagenesis of conserved residues in transmembrane domains 3, 4, 5, and 7 of LPA1–3 predicted to interact with the glycerophosphate motif of LPA C18:1. The mutants were expressed in RH7777 cells, and the efficacy (Emax) and potency (EC50) of LPA-elicited Ca2+ transients were measured. Mutation to alanine of R3.28 universally decreased both the efficacy and potency in LPA1–3 and eliminated strong ionic interactions in the modeled LPA complexes. The alanine mutation at Q3.29 decreased modeled interactions and activation in LPA1 and LPA2 more than in LPA3. The mutation W4.64A had no effect on activation and modeled LPA interaction of LPA1 and LPA2 but reduced the activation and modeled interactions of LPA3. The R5.38A mutant of LPA2 and R5.38N mutant of LPA3 showed diminished activation by LPA; however, in LPA1 the D5.38A mutation did not, and mutation to arginine enhanced receptor activation. In LPA2, K7.36A decreased the potency of LPA; in LPA1 this same mutation increased the Emax. In LPA3, R7.36A had almost no effect on receptor activation; however, the mutation K7.35A increased the EC50 in response to LPA 10-fold. In LPA1–3, the mutation Q3.29E caused a modest increase in EC50 in response to LPA but caused the LPA receptors to become more responsive to sphingosine 1-phosphate (S1P). Surprisingly micromolar concentrations of S1P activated the wild type LPA2 and LPA3 receptors, indicating that S1P may function as a weak agonist of endothelial differentiation gene family LPA receptors.


Received for publication, October 26, 2007 , and in revised form, February 15, 2008.

* This work was supported by United States Public Health Service Grants HL61469 (to G. T.), CA921160 (to G. T.), HL084007 (to A. L. P.), and HL07641-19 (to W. J. V.) and by Southeast American Heart Association Postdoctoral Fellowship 0625325 (to Y. F.) and predoctoral fellowship (to J. I. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2.

1 To whom correspondence should be addressed: Dept. of Physiology, The University of Tennessee Health Science Center Memphis, 894 Union Ave., Memphis, TN 38163. Tel.: 901-448-4793; E-mail: gtigyi{at}physio1.utmem.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.